January 2008-December 2012
Total Page:16
File Type:pdf, Size:1020Kb
CHAPTER 7 List of InternationalInternational CollaborativeCollaborative ResearchResearch ProjectsProjects ApprovedApproved byby HMSC HMSC duringduring January, 2008 2008 to to December, December, 2012 2012 S.no. Detail of Projects 1 The relationship between anti- tuberculosis drug absorption and effective antiretroviral therapy in HIV-TB co-infected patients in Bangalore, India Principal Investigator Funded by Dr. George D'souza Academic Alliance Against AIDS (AAAA), USA Director, St. Johns Medical College, St. Johns Research Institute, St. Johns National Academy of Health Sciences, Date of approval March 2, 2009 Koramangala, Sarjapur Road, Total budget Rs 31, 67,500 Bangalore-560034 Duration 12 Months Subject area HIV/ Tuberculosis 2 Effectiveness of cell phone counseling to improve breast feeding indicators Principal Investigator Funded by Dr. Archana Patel Alive and Thrive Small Grants Program through Professor, Bill & Melinda Gates Foundation, USA Indira Gandhi Government Medical College, Central Avenue Road, Nagpur-440018 Date of approval June 8, 2010 Total budget Rs 44, 99,002 Duration 18 Months Subject area Reproductive Health 3 Field implementation of the helping babies breathe initiative in Belgaum, Karnataka, India Principal Investigator Funded by Dr. Shivaprasad S Goudar American Academy of Pediatrics, USA Professor & Head, Jawaharlal Nehru Medical College, JNMC Campus, Nehru Nagar, Belgaum-590010 Date of approval December 8, 2009 Total budget Rs 24, 00,000 Duration 24 Months Subject area Child Health Research Projects Approved by HMSC Research Projects Approved by HMSC S.no. Detail of Projects 4 Feasibility, acceptability and perceived clinical utility of the cultural formulation interview Principal Investigator Funded by Dr. Smita N Deshpande American Psychiatric Association, USA Head of Department, Dr. Ram Manohar Lohia Hospital, Baba Kharag Singh Marg, New Delhi-110001 Date of approval December 10, 2012 Total budget Rs 1, 16,600 Duration 6 Months Subject area Mental Health 5 Efficacy and safety of AP 12009 in adult patients with recurrent or refractory anaplastic astrocytoma (WHO grade III) as compared to standard treatment with temozolomide or BCNU: A randomized, actively controlled, open label clinical phase III study (SAPPHIRE) Principal Investigator Funded by Dr. Ashish Suri Antisense Pharma GmbH, Germany Associate Professor, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi-110029 Date of approval March 8, 2010 Total budget Rs 36, 52,100 Duration 48 Months Subject area Neurosciences 6 Mission Delhi - Delhi emergency life heart - attack initiative saving hearts, saving lives Principal Investigator Funded by Dr. Balaram Bhargava AUH Hospital, Arhus, Denmark Professor, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi-110029 Date of approval March 12, 2012* Total budget Rs 15, 86, 52,728 Duration 36 Months Subject area Cardiovascular Diseases * Approved with suggestions Research Projects Approved by HMSC ResearchResearch ProjectsProjects ApprovedApproved byby HMSCHMSC S.no. Detail of Projects S.no. Detail of Projects 4 Feasibility, acceptability and perceived clinical utility of the cultural formulation interview 7 Neuro- developmental disabilities among children in India: An INCLEN study Principal Investigator Funded by Principal Investigator Funded by Dr. Smita N Deshpande American Psychiatric Association, USA Dr. M K C Nair Autism Speaks, USA/ INCLEN Inc., USA and National Trust and Ministry of Social Justice and Head of Department, Professor & Director, Empowerment, India Dr. Ram Manohar Lohia Hospital, Child Development Centre, Baba Kharag Singh Marg, Medical College, New Delhi-110001 Thiruvananthapuram-695011 Date of approval December 10, 2012 Date of approval September 8, 2009* Total budget Rs 1, 16,600 Total budget Rs 2, 07, 16, 264 Duration 6 Months Duration 24 Months Subject area Mental Health Subject area Child Health 5 Efficacy and safety of AP 12009 in adult patients with recurrent or refractory anaplastic astrocytoma (WHO grade III) as compared to standard treatment with temozolomide or BCNU: A 8 PASS: Parent-mediated intervention for Autism Spectrum Disorders (ASD) in South Asia randomized, actively controlled, open label clinical phase III study (SAPPHIRE) Principal Investigator Funded by Principal Investigator Funded by Dr. Ashish Suri Antisense Pharma GmbH, Germany Dr. Vikram Patel Autism Speaks, USA Associate Professor, Professor, All India Institute of Medical Sciences Sangath Centre, (AIIMS), Ansari Nagar, 841/1 Alto Porvorim, New Delhi-110029 Goa-403521 Date of approval March 8, 2010 Date of approval September 10, 2012 * Total budget Rs 36, 52,100 Total budget Rs 53, 11,530 Duration 48 Months Duration 24 Months Subject area Neurosciences Subject area Mental Health 6 Mission Delhi - Delhi emergency life heart - attack initiative saving hearts, saving lives 9 The epidemiology and transmission of Tuberculosis (TB) among household contacts in Southern India with a focus on risk factors Principal Investigator Funded by Principal Investigator Funded by Dr. Balaram Bhargava AUH Hospital, Arhus, Denmark Dr. K R John Australian Research Council (ARC), Australia Professor, Professor, All India Institute of Medical Sciences Christian Medical College & Hospital, (AIIMS), Ansari Nagar, Ida Scudder Road, New Delhi-110029 Vellore-632004 Date of approval March 12, 2012* Date of approval June 8, 2010 Total budget Rs 15, 86, 52,728 Total budget Rs 16, 80, 000 Duration 36 Months Duration 12 Months Subject area Cardiovascular Diseases Subject area Tuberculosis * Approved with suggestions * Approved with conditions Indian Council of Medical Research 31 Research Projects Approved by HMSC Research Projects Approved by HMSC S.no. Detail of Projects 10 The development and evaluation of m-Health service in the control of Tuberculosis (TB) in India Principal Investigator Funded by Dr. Dilip Mathai Australian Research Council (ARC), Australia; University of Melbourne, Australia and Bill & Head, Melinda Gates Foundation, USA Christian Medical College & Hospital, Ida Scudder Road, Vellore-632004 Date of approval December 8, 2011 Total budget Rs 54, 85, 500 Duration 36 Months Subject area Tuberculosis 11 A phase III trial of adjuvant chemotherapy following chemo-radiation as primary treatment for locally advanced cervical cancer compared to chemo-radiation alone: The OUTBACK TRIAL Principal Investigator Funded by Dr. S K Shrivastava Australia and New Zealand Gynecological Oncology Group (ANZGOG), Australia Professor & Head, Tata Memorial Hospital, Tata Memorial Centre, Parel, Mumbai-400012 Date of approval December 10, 2012 Total budget Rs 74, 92,000 Duration 36 Months Subject area Oncology 12 The Rishi Valley Vascular Disease Project - An observational and interventional public health project in vascular health in a typical rural South Indian community Principal Investigator Funded by Dr. Kartik Kalyanram Baker H eart Research Institute, Australia Coordinator, Rishi Valley Rural Health Centre, Rishi Valley PO, Madanapalle, Chittor-517352 Date of approval June 8, 2009* Total budget Rs 1, 50, 74,400 Duration 144 Months Subject area Cardiovascular Diseases * Approved with suggestions Research Projects Approved by HMSC ResearchResearch ProjectsProjects Approved Approved by by HMSC HMSC S.no. Detail of Projects S.no. Detail of Projects 10 The development and evaluation of m-Health service in the control of Tuberculosis (TB) in India 13 Novel molecular mechanisms leading to HAEMOPHILIA A phenotype Principal Investigator Funded by Principal Investigator Funded by Dr. Dilip Mathai Australian Research Council (ARC), Australia; Dr. Alok Srivastava Bayer Haemophilia Award, United Kingdom University of Melbourne, Australia and Bill & Head, Melinda Gates Foundation, USA Professor & Head, Christian Medical College & Hospital, Christian Medical College & Hospital, Ida Scudder Road, Ida Scudder Road, Vellore-632004 Vellore- 632004 Date of approval December 8, 2011 Date of approval June 8, 2009 Total budget Rs 54, 85, 500 Total budget Rs 18, 80,000 Duration 36 Months Duration 24 Months Subject area Tuberculosis Subject area Haematology 11 A phase III trial of adjuvant chemotherapy following chemo-radiation as primary treatment for 14 Development and validation of sampling strategies for stopping / continuing Programmes to locally advanced cervical cancer compared to chemo-radiation alone: The OUTBACK TRIAL Eliminate Lymphatic Filariasis (PELF) Principal Investigator Funded by Principal Investigator Funded by Dr. S K Shrivastava Australia and New Zealand Gynecological Dr. S Subramanian Bill & Melinda Gates Foundation, USA Oncology Group (ANZGOG), Australia Professor & Head, Scientist D, Tata Memorial Hospital, Vector Control Research Centre (VCRC), Tata Memorial Centre, Parel, Medical Complex, Indira Nagar, Mumbai-400012 Puducherry-605006 Date of approval December 10, 2012 Date of approval March 25, 2008 Total budget Rs 74, 92,000 Total budget Rs 75, 45,178 Duration 36 Months Duration 15 Months Subject area Oncology Subject area Filariasis 12 The Rishi Valley Vascular Disease Project - An observational and interventional public health 15 Global HIV / AIDS Vaccine Enterprises (GHAVE), Comprehensive Antibody Vaccine Immune project in vascular health in a typical rural South Indian community Monitoring Consortium (GCAV) Principal Investigator Funded by Principal Investigator Funded by Dr. Kartik Kalyanram Baker H eart Research Institute, Australia Dr. Ramesh S Paranjape Bill & Melinda